Earlier this month, Brook Baker posted a Civil Society Statement in support of an upcoming Brazilian legislative proposal that would make greater use of TRIPS flexibilities to promote access to medicines. The legislation will be introduced in August and it will “eliminate patent term extensions and data exclusivity, restrict patents on new forms and new uses and tighten the the inventive step requirement (following the India example), adopt government use procedures, and clarify the role that ANVISA, its drug regulatory agency, plays in the patent examination system.”
The statement is open for endorsement from civil society groups. Marcela Vieira from the Brazilian Interdisciplinary Aids Association has translated the statement into both Spanish and Portuguese. The full statement in English, Spanish and Portuguese, and a short form for institutional endorsements are available here.
In addition to the Civil Society Statement, there is a sign-on letter for academics that is also open for signature. The academics letter is available here.
